Literature DB >> 33255756

DKC1 Overexpression Induces a More Aggressive Cellular Behavior and Increases Intrinsic Ribosomal Activity in Immortalized Mammary Gland Cells.

Ania Naila Guerrieri1,2, Federico Zacchini1,2, Carmine Onofrillo1,2, Sara Di Viggiano1,2, Marianna Penzo1,2, Alessio Ansuini3, Ilaria Gandin3, Yuko Nobe4, Masato Taoka4, Toshiaki Isobe4, Davide Treré1,5, Lorenzo Montanaro1,2,5.   

Abstract

Dyskerin is a nucleolar protein involved in the small nucleolar RNA (snoRNA)-guided pseudouridylation of specific uridines on ribosomal RNA (rRNA), and in the stabilization of the telomerase RNA component (hTR). Loss of function mutations in DKC1 causes X-linked dyskeratosis congenita, which is characterized by a failure of proliferating tissues and increased susceptibility to cancer. However, several tumors show dyskerin overexpression. We observed that patients with primary breast cancers with high dyskerin levels are more frequently characterized by shorter survival rates and positive lymph node status than those with tumors with a lower dyskerin expression. To functionally characterize the effects of high dyskerin expression, we generated stably overexpressing DKC1 models finding that increased dyskerin levels conferred a more aggressive cellular phenotype in untransformed immortalized MCF10A cells. Contextually, DKC1 overexpression led to an upregulation of some snoRNAs, including SNORA67 and a significantly increased U1445 modification on 18S rRNA, the known target of SNORA67. Lastly, we found that dyskerin overexpression strongly enhanced the synthetic activity of ribosomes increasing translational efficiency in MCF10A. Altogether, our results indicate that dyskerin may sustain the neoplastic phenotype from an early stage in breast cancer endowing ribosomes with an augmented translation efficiency.

Entities:  

Keywords:  DKC1; breast cancer; dyskerin; prognosis; pseudouridylation; rRNA; snoRNA

Year:  2020        PMID: 33255756      PMCID: PMC7760958          DOI: 10.3390/cancers12123512

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  41 in total

1.  Multiscale in situ analysis of the role of dyskerin in lung cancer cells.

Authors:  Ignacio Fernandez-Garcia; Tamara Marcos; Arrate Muñoz-Barrutia; Diego Serrano; Ruben Pio; Luis M Montuenga; Carlos Ortiz-de-Solorzano
Journal:  Integr Biol (Camb)       Date:  2013-02       Impact factor: 2.192

2.  Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis.

Authors:  Cristian Bellodi; Olya Krasnykh; Nikesha Haynes; Marily Theodoropoulou; Guang Peng; Lorenzo Montanaro; Davide Ruggero
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

3.  Predictive value of pseudouridine in prostate cancer.

Authors:  Jennifer A Stockert; Akriti Gupta; Bryan Herzog; Shalini S Yadav; Ashutosh K Tewari; Kamlesh K Yadav
Journal:  Am J Clin Exp Urol       Date:  2019-08-25

4.  Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita.

Authors:  Andrew Yoon; Guang Peng; Yves Brandenburger; Yves Brandenburg; Ornella Zollo; Wei Xu; Eduardo Rego; Davide Ruggero
Journal:  Science       Date:  2006-05-12       Impact factor: 47.728

5.  rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells.

Authors:  Karen Jack; Cristian Bellodi; Dori M Landry; Rachel O Niederer; Arturas Meskauskas; Sharmishtha Musalgaonkar; Noam Kopmar; Olya Krasnykh; Alison M Dean; Sunnie R Thompson; Davide Ruggero; Jonathan D Dinman
Journal:  Mol Cell       Date:  2011-11-18       Impact factor: 17.970

6.  Translation initiation factors are not required for Dicistroviridae IRES function in vivo.

Authors:  Nilsa Deniz; Erik M Lenarcic; Dori M Landry; Sunnie R Thompson
Journal:  RNA       Date:  2009-03-19       Impact factor: 4.942

Review 7.  Regulation of snoRNAs in cancer: close encounters with interferon.

Authors:  Shreeram C Nallar; Dhananjaya V Kalvakolanu
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

8.  Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer.

Authors:  Lorenzo Montanaro
Journal:  J Pathol       Date:  2010-12       Impact factor: 7.996

9.  Landscape of the complete RNA chemical modifications in the human 80S ribosome.

Authors:  Masato Taoka; Yuko Nobe; Yuka Yamaki; Ko Sato; Hideaki Ishikawa; Keiichi Izumikawa; Yoshio Yamauchi; Kouji Hirota; Hiroshi Nakayama; Nobuhiro Takahashi; Toshiaki Isobe
Journal:  Nucleic Acids Res       Date:  2018-10-12       Impact factor: 16.971

View more
  7 in total

Review 1.  The Key Role of RNA Modification in Breast Cancer.

Authors:  Yang Liu; Tong Zhu; Yi Jiang; Jiawen Bu; Xudong Zhu; Xi Gu
Journal:  Front Cell Dev Biol       Date:  2022-06-01

Review 2.  Ribosomal RNA Pseudouridylation: Will Newly Available Methods Finally Define the Contribution of This Modification to Human Ribosome Plasticity?

Authors:  Chiara Barozzi; Federico Zacchini; Sidra Asghar; Lorenzo Montanaro
Journal:  Front Genet       Date:  2022-06-01       Impact factor: 4.772

3.  Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes.

Authors:  Claudia Cava; Alexandros Armaos; Benjamin Lang; Gian G Tartaglia; Isabella Castiglioni
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

Review 4.  Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance.

Authors:  Alexandre Garus; Chantal Autexier
Journal:  RNA       Date:  2021-09-23       Impact factor: 4.942

Review 5.  The Potential Role of Small Nucleolar RNAs in Cancers - An Evidence Map.

Authors:  Fanqi Wu; Longguo Zhang; Pingfan Wu; Yi Wu; Tao Zhang; Dekui Zhang; Jinhui Tian
Journal:  Int J Gen Med       Date:  2022-04-08

6.  Human dyskerin binds to cytoplasmic H/ACA-box-containing transcripts affecting nuclear hormone receptor dependence.

Authors:  Federico Zacchini; Giulia Venturi; Veronica De Sanctis; Roberto Bertorelli; Claudio Ceccarelli; Donatella Santini; Mario Taffurelli; Marianna Penzo; Davide Treré; Alberto Inga; Erik Dassi; Lorenzo Montanaro
Journal:  Genome Biol       Date:  2022-08-22       Impact factor: 17.906

7.  The Estrogen Receptor α Signaling Pathway Controls Alternative Splicing in the Absence of Ligands in Breast Cancer Cells.

Authors:  Jamal Elhasnaoui; Giulio Ferrero; Valentina Miano; Santina Cutrupi; Michele De Bortoli
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.